# Observational Primary Myelofibrosis studies: 24 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 24 trials that are observational for Primary Myelofibrosis that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Primary Myelofibrosis studies: 24 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/primary-myelofibrosis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 24
- Recruiting or not yet: 24
- Read on: November 19, 2026

## Trials

The 24 newest of 24, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07925671 | Jaktinib in Ruxolitinib-Treatment Failure Myelofibrosis: A Multicenter, Prospective, Real-World Observational Study | Affiliated Hospital of Nantong University | Observational | Not yet recruiting | Myeloproliferative Neoplasms/Myelofibrosis | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925671) |
| November 9, 2026 | NCT07925632 | A Multicenter, Prospective, Observational Study of Jaktinib in Newly Diagnosed Myelofibrosis | Affiliated Hospital of Nantong University | Observational | Not yet recruiting | Myeloproliferative Neoplasms/Myelofibrosis | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925632) |
| October 7, 2026 | NCT07863466 | MPNdpoint. Single-center, Retrospective, Prospective Study of the Outcome of Patients With Philadelphia-negative Chronic Myeloproliferative... | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Observational | Recruiting | Myelofibrosis (MF), Polycythemia Vera, Essential Thrombocythaemia | 1,190 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07863466) |
| October 1, 2026 | NCT07853417 | Special Stains in Assessment of Bone Marrow Fibrosis | Assiut University | Observational | Not yet recruiting | Bone Marrow Fibrosis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07853417) |
| September 4, 2026 | NCT07805746 | Peri-graft Cytokine Profile: Influence of Hematologic Disease and Donor Type | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Myelofibrosis, Acute Leukemia, Myelodysplastic Syndrome, Hematopoietic Stem Cell Transplant (HSCT) | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07805746) |
| August 19, 2026 | NCT07774455 | Pacritinib Effectiveness in Real-world Settings | Swedish Orphan Biovitrum | Observational | Recruiting | Myelofibrosis (MF) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07774455) |
| May 15, 2026 | NCT07590986 | Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm | Université Catholique de Louvain | Observational | Recruiting | Myeloproliferative Neoplasm (MPN), Polycytemia Vera, Essential Thrombocythemia (ET), Primary Myelofibrosis (PMF) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07590986) |
| January 23, 2026 | NCT07362225 | MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative... | MPN Research Foundation | Observational | Recruiting | Polycythemia Vera, ET (Essential Thrombocythemia), Polycythemia Vera (PV), Essential Thrombocythemia (ET), Primary... | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07362225) |
| November 25, 2025 | NCT07249606 | Momelotinib Effectiveness in Myelofibrosis | Gruppo Italiano Malattie EMatologiche dell'Adulto | Observational | Not yet recruiting | Myelofibrosis (MF) | 93 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07249606) |
| May 16, 2025 | NCT06976918 | Research Platform Myelofibrosis and Anemia | iOMEDICO AG | Observational | Recruiting | Primary Myelofibrosis, Secondary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06976918) |
| March 26, 2025 | NCT06896344 | Role of Mesenchymal Stromal Cell Derived Extracellular Vesicles of Primary Myelofibrosis Patients on CD34+ Cells | Fondazione IRCCS Policlinico San Matteo di Pavia | Observational | Recruiting | Primary Myelofibrosis | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06896344) |
| August 1, 2024 | NCT06533813 | Clinical Epidemiology in Contemporary Patients With Myelofibrosis. | FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | Observational | Recruiting | Myelofibrosis | 617 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06533813) |
| July 24, 2024 | NCT06516406 | Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | Myelofibrosis, Primary Myelofibrosis, Secondary Myelofibrosis | 1,055 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06516406) |
| December 11, 2023 | NCT06164561 | 18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study. | First Affiliated Hospital of Zhejiang University | Observational | Recruiting | Myelofibrosis | 57 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06164561) |
| November 30, 2023 | NCT06151119 | 68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis. | The First Affiliated Hospital of Xiamen University | Observational | Recruiting | Primary Myelofibrosis | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06151119) |
| October 10, 2023 | NCT06073847 | A Post-Marketing Surveillance Study to Assess the Safety of Fedratinib in Korean Patients With Myelofibrosis | Bristol-Myers Squibb | Observational | Recruiting | Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis | 137 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06073847) |
| September 1, 2023 | NCT06022328 | Impact of Epigenetic Age on Clinic-biological Presentation and Prognosis in Myeloproliferative Neoplasms Epigenetic Age in... | University Hospital, Bordeaux | Observational | Recruiting | Myeloproliferative Neoplasm | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06022328) |
| May 31, 2023 | NCT05882773 | Asian Myeloproliferative Neoplasm (MPN) Registry | The University of Hong Kong | Observational | Recruiting | Myeloproliferative Neoplasm, Polycythemia Vera, Essential Thrombocythemia, Post-polycythemia Vera Myelofibrosis... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05882773) |
| March 2, 2018 | NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | Massive Bio, Inc. | Observational | Recruiting | Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver, Cancer of Stomach, Cancer Liver, Cancer of Rectum... | 50,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03452774) |
| October 17, 2016 | NCT02934477 | Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis | Center for International Blood and Marrow Transplant Research | Observational | Recruiting | Myelofibrosis | 650 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02934477) |
| May 3, 2016 | NCT02760238 | Myeloproliferative Neoplasms (MPNs) Patient Registry | University Health Network, Toronto | Observational | Recruiting | Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia, Mastocytosis, Leukemia, Myeloid, Chronic... | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02760238) |
| November 1, 2013 | NCT01973881 | Quantitative MRI for Myelofibrosis | University of Michigan Rogel Cancer Center | Observational | Recruiting | Myelofibrosis | 192 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01973881) |
| June 4, 2010 | NCT01137825 | Registry of Older Patients With Cancer | UNC Lineberger Comprehensive Cancer Center | Observational | Recruiting | Chronic Myeloproliferative Disorders, Cognitive/Functional Effects, Leukemia, Lymphoma, Lymphoproliferative Disorder... | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01137825) |
| June 4, 2010 | NCT01137643 | Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer | UNC Lineberger Comprehensive Cancer Center | Observational | Recruiting | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma... | 15,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01137643) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Affiliated Hospital of Nantong University | 2 |
| First Affiliated Hospital of Zhejiang University | 1 |
| University of Michigan Rogel Cancer Center | 1 |
| MPN Research Foundation | 1 |
| The University of Hong Kong | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
| Center for International Blood and Marrow Transplant Research | 1 |
| Assiut University | 1 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 1 |
| FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| University Health Network, Toronto | 1 |
| Massive Bio, Inc. | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| [Swedish Orphan Biovitrum](https://specstream.ai/data/clinical-trials/company/swedish-orphan-biovitrum) | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| Université Catholique de Louvain | 1 |
| The First Affiliated Hospital of Xiamen University | 1 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
| University Hospital, Bordeaux | 1 |
| [iOMEDICO AG](https://specstream.ai/data/clinical-trials/company/iomedico-ag) | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 7 |
| China | 4 |
| Italy | 4 |
| Germany | 2 |
| Hong Kong | 1 |
| South Korea | 1 |
| Armenia | 1 |
| Poland | 1 |
| Romania | 1 |
| Spain | 1 |
| Canada | 1 |
| Puerto Rico | 1 |
| Belgium | 1 |
| France | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Workers compensation law firms in the United States](https://specstream.ai/data/businesses/workers-compensation-law-firms/united-states)
- [Printing companies in the United States](https://specstream.ai/data/businesses/printing-companies/united-states)
- [HR services firms in the United States](https://specstream.ai/data/businesses/hr-services-firms/united-states)
- [Coffee shops in the United States](https://specstream.ai/data/businesses/coffee-shops/united-states)
- [Wallpaper installers in the United States](https://specstream.ai/data/businesses/wallpaper-installers/united-states)
- [Periodontics practices in the United States](https://specstream.ai/data/businesses/periodontics-practices/united-states)
